Phase Genomics Revenue and Competitors
Estimated Revenue & Valuation
- Phase Genomics's estimated annual revenue is currently $5.9M per year.
- Phase Genomics's estimated revenue per employee is $368,125
Employee Data
- Phase Genomics has 16 Employees.
- Phase Genomics grew their employee count by -53% last year.
Phase Genomics's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder & CEO | Reveal Email/Phone |
2 | COO | Reveal Email/Phone |
3 | VP Business Development | Reveal Email/Phone |
4 | VP Research and Development | Reveal Email/Phone |
5 | Product Marketing Manager | Reveal Email/Phone |
6 | Senior Product Manager | Reveal Email/Phone |
7 | Software Engineer II | Reveal Email/Phone |
8 | Research Scientist | Reveal Email/Phone |
9 | Research Scientist | Reveal Email/Phone |
10 | Senior Bioinformatics Lead | Reveal Email/Phone |
Phase Genomics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $258.5M | 710 | -19% | $1.1B | $2.4B |
What Is Phase Genomics?
Phase Genomics applies Hi-C and other proximity-ligation methods to enable chromosome-scale genome assembly, metagenomic deconvolution, as well as analysis of structural genomic variation and genome architecture. They offer a comprehensive portfolio of laboratory and computational services and products, including Hi-C kits for plants, animals, microbes, and human samples as well as industry-leading genome and metagenome assembly and analysis software. Founded in 2015 by a team of genome scientists, software engineers, and entrepreneurs, the company's mission is to empower scientists with state-of-the-art genomic tools that will accelerate breakthrough discoveries. The company serves academic and commercial researchers in diverse fields and industries.
keywords:N/AN/A
Total Funding
16
Number of Employees
$5.9M
Revenue (est)
-53%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Phase Genomics News
This table compares Denali Therapeutics and Quantum Genomics Société ... The company also develops DNL310 that is in Phase I/II clinical...
Genomic Consortium Diversifies Data, Explores Genomics of Body ... the globe and we look forward to seeing this through to the next phase.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $5.5M | 16 | -43% | N/A |
#2 | $1.3M | 16 | N/A | N/A |
#3 | $1.3M | 16 | N/A | N/A |
#4 | $0.5M | 16 | 0% | $29M |
#5 | $1.3M | 16 | 14% | N/A |